Former Managing Director of Johner Institute Takes Over DACH Leadership at Flinn.ai – Driving Digitalization and Automation of Regulatory Processes

Vienna, March 2025 – With a clear vision to elevate digitalization and automation in the MedTech industry to the next level, Immanuel Bader is joining Flinn.ai after several successful years as Managing Director of the Johner Institute. Flinn.ai has established itself as the market leader in Post-Market Surveillance (PMS) automation in Germany and is now gearing up for European expansion.

Experience in Scaling a Boutique Consultancy

During his tenure at the Johner Institute, Immanuel Bader played a key role in expanding the team from an initial four to 150 employees. “The most important insight from this phase was that targeted digitalization and automation of regulatory processes allow highly qualified professionals to be freed from manual tasks. This enables them to focus on strategic and innovative activities,” explains Immanuel Bader.

New Role at Flinn.ai

As the new Head of DACH, Immanuel Bader will focus on driving the company’s commercial development in the region. “In my first few months, my priority will be to accelerate the rapid growth in Germany, Austria, and Switzerland. We will expand the sales team to better support both existing and potential customers,” says Bader.

“Immanuel Bader will help us strengthen our technological solutions in the DACH market. His experience has shown him exactly how valuable automated workflows are for the growth and innovation of MedTech companies,” adds Bastian Krapinger-Rüther, co-founder of Flinn.ai.

Flinn.ai’s Unique Selling Proposition & European Expansion

Flinn.ai differentiates itself from other providers through its end-to-end PMS automation, which is AI-native—meaning artificial intelligence is strategically deployed to minimize manual processes and relieve regulatory professionals. “This offers enormous opportunities, especially in an international context. We want to help manufacturers focus more on innovation while efficiently meeting complex regulatory requirements,” says Immanuel Bader.

After successfully establishing itself in Germany, with major MedTech companies such as Hartmann, Merck, and Erbe Elektromedizin among its customers, Flinn.ai also serves international clients like Philips and Lifestyles. The company is currently placing a strong focus on expanding into the UK and France.

Future Vision & Market Trends

“In the next three to five years, I see Flinn.ai as the international leader in AI-driven automation of regulatory processes,” forecasts Immanuel Bader. In PMS automation, trends such as deeper AI integration, predictive analytics, and seamless system networking will shape the market. Flinn.ai aims not just to follow these developments but to actively drive them—through continuous AI technology advancements and strategic partnerships across Europe.

A Strong Signal to the Industry

With his move to Flinn.ai, Immanuel Bader sends a clear message: The future of regulatory processes lies in intelligent, automated systems. “My goal is to position Flinn.ai as the leading AI innovation driver in Europe.”

His message to customers and partners is equally clear: “Now is the time to embrace automation. Companies that invest in AI-driven solutions today will secure a competitive advantage and sustainably relieve their teams.”

Flinn.ai continues its strong growth trajectory, and with Immanuel Bader leading the DACH market, the company is well-positioned for its next phase of expansion.